Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04187729 · ClinicalTrials.gov registry record
Precision Genomics Medicine Biobank
A clinical trial of Any Disease Condition and Reportedly-healthy Subjects, sponsored by Intermountain Health Care.
- Recruiting
- Registry status
- 100,000
- Enrollment target
- 1
- Study location
NCT04187729: Recruiting study of Any Disease Condition and Reportedly-healthy Subjects, sponsored by Intermountain Health Care.
NCT04187729 is a study of Any Disease Condition and Reportedly-healthy Subjects that is actively recruiting participants, run by Intermountain Health Care. The registered enrollment target is 100,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04187729, a study of Any Disease Condition and Reportedly-healthy Subjects, is actively recruiting participants, sponsored by Intermountain Health Care.
- RECRUITING
- Registry status
- 100,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.
Primary Outcome
There are no primary endpoints planned for this biobank and endpoints will be specific to future research hypotheses. Investigators anticipate examining genetic and genomic data using a variety of molecular and cellular analysis techniques and in various tissues and fluids.
Conditions Studied
Study Locations (1)
Utah
- Intermountain Healthcare - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100,000 participants |
| Start Date | 2017-10-24 |
| Est. Completion | 2077-10-24 |
What NCT04187729 shows while recruiting
NCT04187729 is an observational study that tracks outcomes without assigning an intervention. Its 100,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Any Disease Condition and Reportedly-healthy Subjects appearing as the primary indexed condition, and to 0 interventions.
NCT04187729 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT04187729 about?
NCT04187729 is a clinical study titled "Precision Genomics Medicine Biobank". The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data ...
What is the current status of trial NCT04187729?
This trial is currently recruiting. The enrollment target is 100,000 participants. The study started on 2017-10-24. Estimated completion is 2077-10-24.
What conditions does trial NCT04187729 study?
This clinical trial studies the following conditions: Any Disease Condition and Reportedly-healthy Subjects.
Who is sponsoring clinical trial NCT04187729?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04187729 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02620852 · 100,000 participants · NA
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- NCT03277365 · 100,000 participants · NA
MyGeneRank: A Digital Platform for Next-Generation Genetic Studies
- NCT04281823 · 100,000 participants
DeBakey Cardiovascular Magnetic Resonance Study
- NCT04869111 · 100,000 participants · NA
The BrainHealth Project
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI